James Campbell's practice centers on the discovery phase of complex litigation, with a particular focus on large-scale government investigations, including cases involving the Foreign Corrupt Practices Act (FCPA), auditing and accounting issues, antitrust actions, and protecting the attorney-client and attorney work product privileges.
Experience
- Pfizer in its $43 billion acquisition of Seagen Inc., a world-leader in antibody-drug conjugates (ADCs).
Credentials
Education
- J.D., George Mason University School of Law, 1992
- B.A., Economics, University of Southern California, 1989
Admissions
- District of Columbia